(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(4-nitrophenyl)propanoate, 95.0%, 1g

1,8-Dibromonaphthalene>98.0%(GC)1g

Dibutyl Phosphite, 95.0%, 100g

1-TERT-BUTYL 3-ETHYL 5,5-DIMETHYL-4-OXOPIPERIDINE-1,3-DICARBOXYLATE, 95.0%, 250mg

3-Fluoro-2-methylbenzaldehyde, 97.0%, 10g

2-(N-Boc-piperidin-3-yl)-1H-benzoimidazole, 95.0%, 5g

Ethyl 2-(6-methoxypyridin-2-yl)acetate, 97%, 1g

1-(2,2-Difluoroethyl)-N-methylpiperidin-4-amine, 98%, 250mg

4-(3,4-Difluorophenoxy)-2-methylaniline, 98%, 250mg

2-(3-Aminobicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride, 98%, 500mg

2-(Benzo[d]oxazol-2-yl)acetonitrile, 95.0%, 250mg

6,7-dimethoxy-1-(4-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, 95.0%, 500mg

Magnesium sulphate heptahydrate, min. 99%, pa, ACS, 500 g, plastic packaging.